Dimensional Fund Advisors LP Lowers Stock Position in InfuSystem Holdings, Inc. (NYSE:INFU)

Dimensional Fund Advisors LP cut its stake in shares of InfuSystem Holdings, Inc. (NYSE:INFU) by 0.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 430,916 shares of the company’s stock after selling 3,927 shares during the quarter. Dimensional Fund Advisors LP owned about 2.02% of InfuSystem worth $2,943,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of INFU. Rhumbline Advisers boosted its stake in InfuSystem by 13.8% in the 2nd quarter. Rhumbline Advisers now owns 17,658 shares of the company’s stock worth $121,000 after buying an additional 2,145 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in InfuSystem by 52.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 26,042 shares of the company’s stock worth $178,000 after buying an additional 8,917 shares during the last quarter. Panagora Asset Management Inc. bought a new stake in shares of InfuSystem during the second quarter valued at approximately $208,000. ARS Investment Partners LLC lifted its holdings in InfuSystem by 11.4% in the second quarter. ARS Investment Partners LLC now owns 33,510 shares of the company’s stock worth $229,000 after purchasing an additional 3,422 shares during the period. Finally, Perritt Capital Management Inc increased its position in shares of InfuSystem by 169.4% during the 2nd quarter. Perritt Capital Management Inc now owns 38,500 shares of the company’s stock valued at $263,000 after purchasing an additional 24,207 shares during the period. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Stock Performance

NYSE:INFU opened at $6.71 on Friday. The company has a market capitalization of $142.89 million, a price-to-earnings ratio of -671,000.00 and a beta of 1.46. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.64 and a current ratio of 2.07. InfuSystem Holdings, Inc. has a 12-month low of $5.74 and a 12-month high of $10.99.

InfuSystem (NYSE:INFU) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). InfuSystem had a return on equity of 0.70% and a net margin of 0.28%. The company had revenue of $33.70 million for the quarter.

Analysts Set New Price Targets

Several research analysts have weighed in on INFU shares. StockNews.com lowered InfuSystem from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 28th. B. Riley began coverage on InfuSystem in a research report on Thursday, September 26th. They issued a “buy” rating and a $13.00 price objective for the company.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.